Your browser doesn't support javascript.
loading
Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized 13C magnetic resonance spectroscopy approaches.
Hong, Donghyun; Kim, Yaewon; Mushti, Chandrasekhar; Minami, Noriaki; Wu, Jing; Cherukuri, Murali Krishna; Swenson, Rolf E; Vigneron, Daniel B; Ronen, Sabrina M.
Afiliación
  • Hong D; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
  • Kim Y; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
  • Mushti C; National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Minami N; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
  • Wu J; National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Cherukuri MK; National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Swenson RE; National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.
  • Vigneron DB; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
  • Ronen SM; Brain Tumor Research Center, UCSF, San Francisco, California, USA.
Neurooncol Adv ; 5(1): vdad143, 2023.
Article en En | MEDLINE | ID: mdl-38024238
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido